Literature DB >> 28696573

Prognostic implications of Q waves at presentation in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An analysis of the HORIZONS-AMI study.

Ioanna Kosmidou1,2, Björn Redfors1, Aaron Crowley1, Bernard Gersh3, Shmuel Chen1, José M Dizon1,2, Monica Embacher1, Roxana Mehran1,4, Ori Ben-Yehuda1, Gary S Mintz1, Gregg W Stone1,2.   

Abstract

BACKGROUND: Presence of Q waves on the presenting electrocardiogram (ECG) in patients with ST-segment elevation myocardial infarction (STEMI) has been associated with worse prognosis; however, whether the prognostic value of Q waves is influenced by baseline characteristics and/or rapidity of revascularization based on the guideline-based metric of door-to-balloon time remains unknown. HYPOTHESIS: We hypothesized that Q waves in the presenting ECG will be predictive of long term mortality regardless of time to reperfusion.
METHODS: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial enrolled 3602 patients with STEMI undergoing primary percutaneous coronary intervention. We stratified patients without prior history of myocardial infarction or coronary revascularization according to presence or absence of pathological Q waves on their presenting ECG. Associations between Q waves, death, and cardiovascular outcomes within 3 years were assessed using Cox proportional hazards regression.
RESULTS: Among 2723 patients with evaluable ECGs, 1084 (39.8%) had Q waves on their presenting ECG. Male sex and time from symptom onset to balloon inflation were independent predictors of presence of Q waves. Patients with Q waves had higher adjusted risks of all-cause death (adjusted hazard ratio: 1.45, 95% confidence interval: 1.02-2.05, P = 0.04) and cardiac death (adjusted hazard ratio: 1.72, 95% confidence interval: 1.08-2.72, P = 0.02). The association between Q waves and cardiac death was consistent regardless of sex, diabetes status, target vessel, or door-to-balloon time (Pinteraction > 0.4 for all).
CONCLUSIONS: Presence of Q waves on the presenting ECG in patients undergoing primary percutaneous coronary intervention due to STEMI is an independent predictor of mortality and adds prognostic value, regardless of sex or rapidity of revascularization.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Myocardial Infarction; Primary Percutaneous Coronary Intervention; Q Waves

Mesh:

Year:  2017        PMID: 28696573      PMCID: PMC6490428          DOI: 10.1002/clc.22751

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  20 in total

1.  Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era.

Authors:  Matthew B Kahn; Richard M Cubbon; Ben Mercer; Alison C G Wheatcroft; Guy Gherardi; Amir Aziz; Vivek Baliga; Jonathan M Blaxill; Jim M McLenachan; Daniel J Blackman; John P Greenwood; Stephen B Wheatcroft
Journal:  Diab Vasc Dis Res       Date:  2011-11-08       Impact factor: 3.291

2.  Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2.

Authors:  Cheuk-Kit Wong; Wanzhen Gao; O Christopher Raffel; John K French; Ralph A Stewart; Harvey D White
Journal:  Lancet       Date:  2006-06-24       Impact factor: 79.321

3.  The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators.

Authors:  Paul A Scott; John M Morgan; Nicola Carroll; David C Murday; Paul R Roberts; Charles R Peebles; Stephen P Harden; Nick P Curzen
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-04-14

4.  Size and transmural extent of first-time reperfused myocardial infarction assessed by cardiac magnetic resonance can be estimated by 12-lead electrocardiogram.

Authors:  Henrik Engblom; Erik Hedström; Einar Heiberg; Galen S Wagner; Olle Pahlm; Håkan Arheden
Journal:  Am Heart J       Date:  2005-11       Impact factor: 4.749

5.  Infarct morphology identifies patients with substrate for sustained ventricular tachycardia.

Authors:  David Bello; David S Fieno; Raymond J Kim; F Scott Pereles; Rod Passman; Gina Song; Alan H Kadish; Jeffrey J Goldberger
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

6.  Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial.

Authors:  Hany Siha; Debraj Das; Yuling Fu; Yinggan Zheng; Cynthia M Westerhout; Robert F Storey; Stefan James; Lars Wallentin; Paul W Armstrong
Journal:  CMAJ       Date:  2012-04-30       Impact factor: 8.262

Review 7.  Initial Q waves and outcome after reperfusion therapy in patients with ST elevation acute myocardial infarction: a systematic review.

Authors:  Cheuk-Kit Wong; Peter Herbison
Journal:  Int J Cardiol       Date:  2009-12-14       Impact factor: 4.164

8.  Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.

Authors:  Roxana Mehran; Alexandra J Lansky; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; S Chiu Wong; Eugenia Nikolsky; Louise Gambone; Lynn Vandertie; Helen Parise; George D Dangas; Gregg W Stone
Journal:  Lancet       Date:  2009-08-28       Impact factor: 79.321

9.  Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.

Authors:  Paul W Armstrong; Yuling Fu; Cynthia M Westerhout; Michael P Hudson; Kenneth W Mahaffey; Harvey D White; Thomas G Todaro; Peter X Adams; Philip E G Aylward; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2009-04-28       Impact factor: 24.094

10.  Bivalirudin during primary PCI in acute myocardial infarction.

Authors:  Gregg W Stone; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; George Dangas; S Chiu Wong; Ajay J Kirtane; Helen Parise; Roxana Mehran
Journal:  N Engl J Med       Date:  2008-05-22       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.